Eli Lilly and Co. is making an $850 million investment on manufacturing and research in the U.S. in 2017 and that includes Indianapolis. CEO Dave Ricks talks about what’s fueling the investment, and if more could be on the way.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}